Aids In India
This paper revolves around the Public health related aspects of industrial and intellectual property rights policies in a developing country with respect to Aids in India. It also focusses on its preventive measures, status of the epidemic with referance to the Indian Specificities, measures of Public health, availability and knowledge of condoms, NACO's effort to spread awareness and the ARV production in India with main players as in Cipla and Ranbaxy. [CSH OP NO 8]
When requesting a correction, please mention this item's handle: RePEc:ess:wpaper:id:1974. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Padma Prakash)
If references are entirely missing, you can add them using this form.